Evidence-Based Integrative Therapies in Breast Cancer
With the large number of patients and survivors already using non-conventional therapies, it is critical for oncology professionals to understand the importance of asking their patients about such modalities and to be knowledgeable enough to discuss the risks, benefits, and goals of non-conventio
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Locoregional Treatment of Breast Cancer, Including SABCS Updates
Locoregional management strategies have considerably evolved.  Although several randomized studies have identified patients that do not need ALND, a recent survey revealed substantial variation in surgeon management suggesting the potential for overtreatment of many patients and the need for educ
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Neoadjuvant and Adjuvant Therapies for Early Stage Breast Cancer, Including SABCS Updates
This information was originally presented at the NCCN 2019 Congress Series™: Breast Cancer with Updates from the 2018 San Antonio Breast Cancer Symposium (SABCS) held in Chicago, Illinois, on February 8, 2019.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
PARP Inhibitors in Breast Cancer: Expert Perspectives on Clinical Application and Genetic Testing
The goal of this activity is to improve participants' knowledge of, confidence in, and competence in integrating PARP inhibitors into treatment of patients with breast cancer.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN 2018 Nursing Program Webinar Series - Improving Quality of Care for Lesbian, Gay, Bisexual, and Transgender (LGBT) Patients
LGBT individuals may show an increased incidence of certain cancers, but are less likely to receive regular medical care and standard cancer screenings. This lack of adequate medical care may be partially due to stigma and discrimination in health care settings.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN 2018-2019 Oncology Case Manager and Medical Director Program: Cancer 101
As multidisciplinary cancer care becomes increasingly common, it is important for all members of the care team to understand the basics of cancer biology, diagnosis, and treatment to best care for their patients.
Category
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
NCCN Guidelines® Insights - Hepatobiliary Cancers, Version 2.2019
The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for cancers of the liver, gallbladder, and bile ducts.
Category
  • Hepatocellular Carcinoma
Format
  • Monograph/Journal Supplement
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN 2018-2019 Oncology Case Manager and Medical Director Program: Recognition and Management of Immunotherapy-Related Toxicity
Immunotherapy-related toxicity impacts the majority of patients receiving cancer immunotherapy, and a significant proportion of patients experience higher-grade immune-related adverse events (irAEs).
Category
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Management of Adverse Events From Cancer Immunotherapy: Resources for Emergency Medicine Specialists
The goal of this activity is to improve the knowledge, competence, and performance of physicians and other clinicians who provide emergency care for patients with cancer who are experiencing an immune-related adverse event from immune checkpoint inhibitor therapy.
Category
Format
  • Recorded Webcast
Credits
  • AMA PRA Category 1 Credit™
  • Participation
NCCN Guidelines® Insights - Pancreatic Adenocarcinoma, Version 1.2019
The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making.
Category
  • Pancreatic Cancer
Format
  • Monograph/Journal Supplement
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation

Pages